More information: Le Li et al, Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions, Journal of Clinical and Translational Hepatology (2024). DOI ...

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and is the third leading cause of cancer-related deaths. The primary curative treatments for HCC are liver ...

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and is the third leading cause of cancer-related deaths. The primary curative treatments for HCC are liver ...

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and is the third leading cause of cancer-related deaths. The primary curative treatments for HCC are liver ...

Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma? Yizhen Fu, Yaojun Zhang, Dandan Hu, Zhongguo Zhou, Li Xu, Minshan Chen Journal of Clinical Oncology 2025 43: 14, 1625-1630. View ...

When hepatocellular carcinoma (HCC) is centrally adherent to major vessels, radiotherapy administered after surgery improves outcomes even in the setting of negative surgical margins, according to ...

Hepatocellular carcinoma (HCC) ... (TACE) performed 4-8 weeks after hepatectomy is an adjuvant treatment used to reduce risks of postoperative recurrence and improve long-term prognosis.

There are many treatments for hepatocellular carcinoma. It's a big decision, so work closely with your doctor to make the right plan for you. Your choices may include: Radiation.

Hepatocellular carcinoma (HCC), a prevalent form of cancer, profoundly influences the progression and prognosis of the disease through immune response mechanisms. Skip to content.

Candidate genes in canine hepatocellular carcinoma for molecular targeted therapy. BMC Research Notes , 2024; 17 (1) DOI: 10.1186/s13104-024-07016-y Cite This Page : ...

More information: Le Li et al, Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered ...